Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Conditions: Hemangioma; Kaposiform Hemangioendothelioma Interventions: Drug: Sirolimus(0.8mg/m2); Drug: Sirolimus(0.7mg/m2) Sponsor: Children's Hospital of Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials